v3.25.4
Consolidated Statements of Cash Flows - USD ($)
 3 Months Ended 12 Months Ended
Jun. 29, 2025
Dec. 28, 2025
Dec. 29, 2024
Dec. 31, 2023
CASH FLOWS PROVIDED BY OPERATING ACTIVITIES:        
Net (loss)/income   $ (523,779,000) $ 3,815,000 $ (36,647,000)
Adjustments to reconcile net (loss)/income to net cash provided by operating activities:        
Depreciation and amortization expense   137,074,000 133,597,000 125,894,000
Deferred and other income taxes   (35,552,000) 3,067,000 (18,486,000)
Goodwill impairment   355,958,000 0 0
Loss on extinguishment of debt   0 0 472,000
Long-lived asset impairment and lease termination charges   76,464,000 4,464,000 24,909,000
Loss on disposal of property and equipment   1,643,000 1,250,000 110,000
Loss/(gain) on divestiture of Insomnia Cookies $ (11,500,000) 11,501,000 (90,455,000) 0
Gain on refranchising   (1,358,000) 0 0
Gain on remeasurement of equity method investment   0 (5,579,000) 0
Gain on sale-leaseback   (6,749,000) (1,569,000) (9,646,000)
Share-based compensation   12,865,000 35,149,000 24,196,000
Change in accounts and notes receivable allowances   1,443,000 646,000 654,000
Inventory write-off   6,328,000 2,783,000 11,248,000
Settlement of interest rate swap derivatives   0 0 7,657,000
Amortization related to settlement of interest rate swap derivatives   0 (5,910,000) (10,289,000)
Other   2,064,000 (619,000) 2,155,000
Change in operating assets and liabilities, excluding business acquisitions and divestitures, and foreign currency translation adjustments:        
Accounts, notes, and taxes receivable   5,484,000 (13,895,000) (3,523,000)
Inventories   (19,870,000) (2,011,000) 780,000
Other current and noncurrent assets   (4,405,000) (873,000) (2,395,000)
Operating lease assets and liabilities   (943,000) (1,227,000) 5,111,000
Accounts payable and accrued liabilities   15,079,000 (20,156,000) (74,471,000)
Other long-term obligations and deferred credits   677,000 3,355,000 (2,185,000)
Net cash provided by operating activities   33,924,000 45,832,000 45,544,000
CASH FLOWS (USED FOR)/PROVIDED BY INVESTING ACTIVITIES:        
Purchase of property and equipment   (97,929,000) (120,792,000) (121,427,000)
Proceeds from disposals of assets   3,077,000 183,000 218,000
Proceeds from sale-leaseback   10,882,000 6,308,000 10,025,000
Acquisition of shops and franchise rights from franchisees, net of cash acquired   0 (31,938,000) 0
Purchase of equity method investment   (2,998,000) (3,506,000) (1,424,000)
Net proceeds from divestiture of Insomnia Cookies $ 75,000,000.0 75,000,000 124,126,000 0
Principal payment received from loan to Insomnia Cookies   0 45,000,000 0
Principal payments received from loans to franchisees   1,202,000 985,000 20,000
Disbursement for loan receivable   1,379,000 1,086,000 0
Net cash (used for)/provided by investing activities   (12,145,000) 19,280,000 (112,588,000)
CASH FLOWS (USED FOR)/PROVIDED BY FINANCING ACTIVITIES:        
Proceeds from the issuance of debt   778,538,000 676,250,000 1,175,698,000
Repayment of long-term debt and lease obligations   (728,602,000) (712,778,000) (1,084,390,000)
Payment of financing costs   (825,000) 0 (5,175,000)
Proceeds from structured payables   291,028,000 376,189,000 241,148,000
Payments on structured payables   (334,576,000) (345,327,000) (214,574,000)
Payment of contingent consideration related to a business combination   0 0 (925,000)
Capital contribution from shareholders, net of loans issued   0 919,000 764,000
Proceeds from sale of noncontrolling interest in subsidiary   0 1,562,000 292,000
Distribution to shareholders   (11,934,000) (23,692,000) (23,558,000)
Payments for repurchase and retirement of common stock   (1,350,000) (5,489,000) (1,880,000)
Distribution to noncontrolling interest   (36,000) (41,583,000) (15,538,000)
Net cash (used for)/provided by financing activities   (7,757,000) (73,949,000) 71,862,000
Effect of exchange rate changes on cash, cash equivalents and restricted cash   (446,000) (462,000) (1,934,000)
Net increase/(decrease) in cash, cash equivalents and restricted cash   13,576,000 (9,299,000) 2,884,000
Cash, cash equivalents and restricted cash at beginning of the fiscal year   29,315,000 38,614,000 35,730,000
Cash, cash equivalents and restricted cash at end of the fiscal year   42,891,000 29,315,000 38,614,000
Supplemental schedule of non-cash investing and financing activities:        
(Decrease)/increase in accrual for property and equipment   (18,443,000) 14,214,000 51,820,000
Accrual for distribution to shareholders   0 (5,952,000) (5,902,000)
Reconciliation of cash, cash equivalents and restricted cash at end of fiscal year:        
Cash and cash equivalents   42,390,000 28,962,000 38,185,000
Restricted cash   501,000 353,000 429,000
Total cash, cash equivalents and restricted cash   $ 42,891,000 $ 29,315,000 $ 38,614,000